Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa. (Q54145368)

25 May 2018

title

Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa. (English)

1 reference

25 May 2018

0 references

2

1 reference

25 May 2018

author name string

Gianotti L

1

1 reference

25 May 2018

Valetto MR

3

1 reference

25 May 2018

Ramunni J

4

1 reference

25 May 2018

Di Vito L

5

1 reference

25 May 2018

Maccagno B

6

1 reference

25 May 2018

Camanni F

7

1 reference

25 May 2018

Ghigo E

8

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

25 May 2018

published in

Biological Psychiatry

1 reference

25 May 2018

volume

43

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

181-187

1 reference

25 May 2018

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Growth Hormone in Malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year followup compared to control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Growth hormone neuroregulation and its alterations in disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Effects of alpha- and Beta-adrenergic agonists and antagonists on growth hormone secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Catecholamine metabolism in primary anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Anorexia Nervosa: Recent Investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Catecholamine metabolism in anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Beta-adrenergic stimulation of growth hormone (GH) release in vivo, and subsequent inhibition of GH-releasing factor-induced GH secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Beta 2-adrenergic receptor regulation in circulating mononuclear leukocytes in anorexia nervosa and bulimia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Atenolol enhances growth hormone release to exogenous growth hormone-releasing hormone but fails to alter spontaneous nocturnal growth hormone secretion in boys with constitutional delay of growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Selective beta 1-adrenergic receptor-blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Acquired growth hormone resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Binding of [3H]clonidine and [3H]WB4101 to the pre- and postsynaptic alpha-adrenoceptors of the basal hypothalamus of the starved male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Reduction in cortical beta adrenergic receptor density after chronic intermittent food deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Potential regulators of feeding behavior In anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

Hypothalamic-pituitary function in anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900014-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(97)00014-0

1 reference

25 May 2018

1 reference

25 May 2018